Caplin Point Laboratories has received an approval for the slump sale of business undertaking of the Company (Regulated Markets Injectable Business, including USFDA approved Injectable plant) to its wholly owned subsidiary company which is in the process of being incorporated. The Board of Directors of the company at their meeting …
Read More »